جست‌وجوی استاد و پژوهشگر

Ard Nijhofمشاهده پروفایل

استاد

• Parasitology
• Tropical Veterinary Medicine
• Vector-borne Diseases
• +۴ مورد دیگر

Univ.-Prof. Ard Nijhof, PhD is a Professor and Head of the Tropical Veterinary Medicine Working Group at the Institute of Parasitology and Tropical Veterinary Medicine within the Department of Veterinary Medicine at Freie Universität Berlin. His office is located at Robert-von-Ostertag-Str. 7, Room 012, 14163 Berlin, Germany. Dr. Nijhof's research focuses on parasitology and tropical veterinary medicine with particular emphasis on tick-host-pathogen interactions, vector-borne diseases, and zoonotic infections. His work spans molecular investigations of vector competence, field epidemiology of tick-borne diseases, and development of novel control strategies including anti-tick vaccines. His research integrates laboratory, field, and molecular approaches to understand transmission dynamics of pathogens like Borrelia , Rickettsia , and Theileria species. Dr. Nijhof has published extensively on tick-borne diseases, with recent work examining decontamination protocols for tick microbiota, Rift Valley fever epidemiology in Uganda, and genetic aspects of arthropod vectors. His publications show consistent output with 6 publications in 2024 and 6 in 2025 (including preprints), demonstrating active ongoing research. His research has practical applications in disease control and prevention, particularly through projects like ANTIDotE (anti-tick vaccines to prevent tick-borne diseases in Europe). He collaborates internationally with researchers across Europe, Africa, and Asia on vector-borne disease research. Dr. Nijhof serves as a key member of the Center for Infectious Diseases at Freie Universität Berlin and contributes to scholarly initiatives such as hosting Sudanese veterinarian Khalid Mohammedsalih from Nyala University as a Scholar Rescue Fund fellow.

• Infectious Diseases
• Clinical Microbiology
• Antimicrobial Resistance
• +۳ مورد دیگر

Kendall D Kling is an Assistant Professor at Northwestern University Feinberg School of Medicine with joint appointments in the Department of Pathology (Microbiology division) and the Department of Medicine (Infectious Diseases division). Board-certified in Internal Medicine, Infectious Diseases, and Medical Microbiology (ABMM 2023), he practices clinically at Northwestern Memorial Hospital. His educational pathway includes: MD (2016) Internal Medicine Residency, University of Chicago (2019) Infectious Diseases Fellowship, Northwestern University (2021) Medical and Public Health Laboratory Microbiology Fellowship, Northwestern University (2023) Dr. Kling's research integrates clinical microbiology and infectious diseases with emphases on antimicrobial resistance mechanisms, hospital epidemiology, and public health surveillance. His work develops diagnostic frameworks to reduce unnecessary antibiotic use while addressing multidrug-resistant pathogen outbreaks and complex device-associated infections through genomic and molecular methodologies. Recent publications (2024-2025) reveal consistent focus on antimicrobial resistance diagnostics and outbreak response, particularly in urinary tract infections, sexually transmitted bacterial clusters among vulnerable populations, and novel treatment approaches for extensively drug-resistant organisms. His studies frequently employ whole-genome sequencing to trace transmission pathways in healthcare settings. Professional recognition includes: Faculty Teaching Award, Department of Medicine (2024) No formal student advisement or grant funding details are disclosed in available sources. Dr. Kling maintains active collaborations with clinical microbiology laboratories and public health agencies through his dual-departmental roles, though specific research team structures are not documented publicly.

Fred Asiegbuمشاهده پروفایل

استاد

• Forest Pathology
• Molecular Tree-Microbe Interaction
• Tree Microbiomes
• +۸ مورد دیگر

Professor Fred Asiegbu is a distinguished researcher and educator in forest pathology at the University of Helsinki. He holds the position of Professor of Forest Pathology in the Department of Forest Sciences, with additional affiliations at the Institute of Sustainability Science (HELSUS) and Viikki Plant Science Centre (ViPS). Professor Asiegbu also serves as an invited Professor at Nanjing Forestry University in China and supervises doctoral students across three Doctoral Programmes: Integrative Life Science, Plant Sciences, and Sustainable Use of Renewable Natural Resources. Professor Asiegbu's educational foundation includes: PhD in Biotechnology (1988-1991, awarded 1992) MSc in Applied Microbiology & Plant Pathology (1984-1985, awarded 1986) BSc in Botany (1979-1983, awarded 1983) His research program addresses critical challenges in sustainable forest management through innovative biotechnology approaches. Professor Asiegbu leads investigations into molecular tree-microbe interactions, tree microbiomes, fungal genomics, and biological control of forest pathogens. His work focuses on understanding the molecular and biochemical pathways required by fungal pathogens to infect trees and the mechanisms by which forest trees resist infection. A central research question explores why certain fungi are pathogenic while others form beneficial associations like mycorrhizae. His team applies metabolomics and genomics approaches to screen conifer genotypes for resistance against pathogens like Heterobasidion spp., with the goal of developing novel disease control strategies and informing resistance breeding programs. Analysis of Professor Asiegbu's recent publications reveals a strong interdisciplinary focus spanning molecular biology, genomics, metabolomics, and ecological studies of tree-pathogen interactions. His work predominantly investigates the Heterobasidion pathosystem in coniferous trees, particularly Norway spruce, while also exploring the protective roles of beneficial microbes in enhancing tree resistance. The research integrates fundamental biological insights with practical applications for forest health management in the context of climate change threats to forest ecosystems. Professor Asiegbu has supervised multiple doctoral students on topics related to conifer resistance mechanisms, Heterobasidion pathogenesis, and co-infection dynamics. He leads significant research projects including 'Heterobasidion barrträd patosystem' (2024-2028), 'Bright' (2023-2025), and participates in the Viikki Plant Science Centre and NaPPI infrastructure initiatives, with funding primarily from the Academy of Finland. As director of the Forest Pathology Research Lab, Professor Asiegbu oversees a research program that applies modern biotechnology tools to understand tree-microbe interactions across natural forests, plantations, and urban environments. His work serves public and environmental interests by developing scientific approaches to prevent and control tree diseases, addressing both biotic factors (particularly fungal diseases) and abiotic factors (such as climate change impacts) affecting forest health.

Felipe A. Lisboaمشاهده پروفایل

عضو هیئت علمی

• Surgical Critical Care
• Precision Medicine
• Inflammatory Response
• +۵ مورد دیگر

Felipe A. Lisboa, M.D. is a Research Assistant Professor in the Department of Surgery at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine in Bethesda, MD. He serves as the Surgical Critical Care Initiative (SC2i) Associate Director of Clinical Research and SC2i USU/WR Biorepository Director. With over ten years of experience in both basic and clinical research, Dr. Lisboa has established himself as a prominent researcher in surgical critical care, precision medicine, and inflammatory response mechanisms. Dr. Lisboa's research interests span surgical critical care, precision medicine, inflammatory response mechanisms, trauma and wound healing, angiogenesis, immunology, molecular biology, and the application of machine learning in clinical research. His work particularly focuses on multiomics approaches (genomics, proteomics, and metabolomics) to understand surgical complications including wound failure, local infection, sepsis, pneumonia, ARDS, AKI, and VTE in military and civilian patients. His publication record demonstrates a clear progression from fundamental molecular immunology research to applied clinical trauma medicine, with recent work emphasizing precision medicine approaches to surgical decision-making. His articles reveal a consistent focus on inflammatory biomarkers, wound healing mechanisms, and computational methods to improve outcomes for trauma patients. Dr. Lisboa's scientific contributions include developing clinical decision support tools, expanding the SC2i USU/WR Biorepository inventory, and implementing clinical study protocols for surgical critical care research. His work bridges basic science with clinical applications, particularly in combat casualty care.

Noam Auslanderمشاهده پروفایل

استادیار

• Machine Learning
• Cancer Genomics
• Tumor Microbiome
• +۴ مورد دیگر

Noam Auslander, Ph.D. is an Assistant Professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute's Ellen and Ronald Caplan Cancer Center. She joined The Wistar Institute in 2021 after completing postdoctoral training at the National Center of Biotechnology Information (NCBI). Dr. Auslander holds a B.S. in computer science and biology from Tel Aviv University and earned her Ph.D. in computer science from the University of Maryland with a combined fellowship at the National Cancer Institute. Dr. Auslander's research focuses on developing advanced machine and deep learning methods to identify factors that drive cancer development and predict patient prognoses. Her work specifically targets the development of deep learning methods to identify new infectious agents in cancer and biologically interpretable machine learning strategies that improve outcome prediction. Her laboratory has several key research directions: Characterization of the Tumor Microbiome with Machine Learning, Quantification of Gut Microbial Genes and Development of Fecal Biomarkers, New Virus Characterization and Detection of Pathogenic Viral Sequences, and Biologically Informed Classifiers of Cancer Treatment Responses. Her publication record demonstrates a strong trajectory in computational cancer biology, with recent high-impact publications in Nature Communications, Nature Medicine, and other top-tier journals. Her work bridges the gap between complex computational methods and biological insights, with particular emphasis on making machine learning models biologically interpretable for clinical translation. V Foundation Grant for Cancer Research ($600,000) Women Scientists Innovation Award for Cancer Research Dr. Auslander leads a research team including a postdoctoral fellow (Abdurrahman Elbasir), graduate students (Anastasia Lucas, Andrew Patterson, Julia C Malnak), and research staff (McKenna Reale, Bryant Duong). Her lab received significant funding for a project aimed at improving immunotherapy responses in cancer patients by identifying reliable biomarkers that predict patient responses to immunotherapy treatments.

Karen Eilbeckمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Precision Medicine
• +۵ مورد دیگر

Karen Eilbeck is Professor of Biomedical Informatics and Adjunct Associate Professor of Human Genetics at the University of Utah , where she directs a bioinformatics research lab focused on precision medicine and genomic data management. Education B.S., University of Salford, United Kingdom Ph.D., University of Manchester, United Kingdom Research Interests The Eilbeck lab leverages computer science and ontology engineering to address contemporary questions in genomics and molecular biology. Central themes include: Development of ontologies such as the Sequence Ontology (SO) and Non-Coding RNA Ontology (NCRO) to standardize and structure biological data. Design of ontology-enabled software tools that enhance data sharing, variant interpretation, and precision medicine workflows. Metagenomic pathogen detection, clinical genome interpretation, and integration of multi-omics datasets to advance personalized healthcare. Publication Trends Recent publications (2023-2025) emphasize AI-driven clinical decision support, standardized genomic terminology, and large-scale infectious-disease risk modeling. Earlier works (2005-2018) established foundational ontologies and data formats (GVF, VCF) now widely adopted by the genomics community. Contact & Resources Email: keilbeck@genetics.utah.edu Lab website: available via University of Utah Department of Biomedical Informatics Full publication list: PubMed search | Google Scholar

Sharif S. Alyمشاهده پروفایل

استاد

• Veterinary Medicine
• Epidemiology
• Infectious Diseases
• +۶ مورد دیگر

Sharif S. Aly is a Professor of Epidemiology and Biostatistics in the Department of Population Health and Reproduction at the School of Veterinary Medicine, University of California, Davis. He has been a faculty member since May 2010, developing quantitative and epidemiological methods to advance the health, welfare and productivity of food animals. Dr. Aly is also enthusiastic about teaching epidemiology to veterinary and graduate students. As a veterinary epidemiologist, Dr. Aly specializes in dairy cattle infectious diseases and welfare. His research interests span Veterinary Medicine, Epidemiology, Infectious Diseases, Dairy Cattle Health, Antimicrobial Resistance, Data Science, Machine Learning, and Population Health. He develops innovative quantitative approaches to address complex challenges in food animal health and productivity. Dr. Aly's publication record demonstrates a strong focus on antimicrobial resistance, dairy cattle health, and diagnostic methods. His work frequently employs advanced statistical methods, machine learning approaches, and epidemiological modeling. Recent publications show increasing emphasis on the One Health approach, connecting animal health, human health, and environmental factors, particularly in relation to antimicrobial resistance and food safety. Dr. Aly serves as an Editorial Board Member for PeerJ - the Journal of Life & Environmental Sciences, reflecting his standing in the scientific community. His contributions as an author, reviewer, and editor demonstrate his commitment to advancing research in veterinary medicine and epidemiology. Dr. Aly leads the Dairy Epi Lab (Aly Lab), which focuses on effectively surveying large populations, novel scoring systems, diagnostic strategies, and risk assessment development. The lab collaborates with various research teams dedicated to improving dairy cattle health and productivity through evidence-based approaches, particularly in the areas of calf and adult cow health, foodborne pathogens, and antimicrobial resistance.

Søren Rosendahlمشاهده پروفایل

استاد

• Molecular Ecology
• Population Genetics
• Evolution of Fungi
• +۴ مورد دیگر

Søren Rosendahl is a Professor in Ecology and Evolution at the Department of Biology, Faculty of Science, University of Copenhagen. He holds a PhD and has been recognized as a Knight (Ridder af Dannebrog) for his contributions to science. His academic career spans over three decades at the University of Copenhagen, where he served as Assistant Professor (1991), Associate Professor (1994), and Professor (2000) in the Department of Mycology, which later became part of the Department of Biology. From 2010-2019, he served as Deputy Head of the Department of Biology. Education: 1984: Master of Science (Cand.scient.) in biology, University of Copenhagen 1985: Practical and theoretical training as high school teacher in biology 1989: Ph.D. (Lic.scient) at Institut for Sporeplanter Professor Rosendahl specializes in molecular ecology, population genetics, and evolution of fungi, with particular emphasis on biotrophic symbionts and parasites. His research encompasses Fusarium, Penicillium, Oomycota (Peronosporamycota), arbuscular mycorrhizal fungi (AMF) in Glomales, and fungi associated with insects. He employs advanced genomic techniques including rad-sequencing, microsatellites, SNPs, and DNA sequencing to study fungal diversity and distribution patterns. His BioMark project applies population genomics to predict emerging epidemics of Phytophthora infestans (Potato late blight). He also investigates molecular diversity of AMF fungi in agricultural and natural environments using evolutionary and demographic models based on coalescence and MCMC Bayesian statistics. Analysis of Professor Rosendahl's recent publications reveals a strong interdisciplinary focus spanning fungal ecology, medical microbiology, and agricultural science. His work demonstrates consistent application of molecular genetic approaches to understanding fungal community dynamics across diverse ecosystems - from soil microbial communities to human gut microbiomes. The trend shows increasing integration of computational approaches including hierarchical joint species modeling and co-occurrence networks for microbial community data analysis. His research bridges fundamental fungal biology with practical applications in agriculture, medicine, and environmental science. Scientific Recognition: Knight (Ridder af Dannebrog) Throughout his career, Professor Rosendahl has held numerous leadership and advisory positions. He served as Head of the Department of Mycology (1998-2001), Coordinator for the Bachelor degree in Industrial Science (2002-2005), and Head of the Study Board for Biology (2005-2007). He has represented Danish higher education on the Biology/Biotechnology board in the Ministry of Education since 2010 and has consulted for international organizations including the EC Commission, Norwegian Ministry for Education, and European Baccalaureate Unit. His external collaborations include significant work with Novozymes Biologicals and Thomsen BioScience A/S. Professor Rosendahl maintains active research collaborations through his membership in the European culture collection (BEG - Bank of European Glomales) and has served as Danish representative in multiple COST actions. His research group appears to focus on fungal population genetics with applications spanning agricultural systems, natural ecosystems, and medical contexts.

Julia Zhangمشاهده پروفایل

دانشیار بالینی

• Medical Oncology
• Hematology
• Cancer Research
• +۲ مورد دیگر

Julia Zhang, M.D., Ph.D., is an Academic Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine. She practices at the Fred Hutchinson Cancer Center at Overlake Cancer Center in Bellevue, Washington, where she provides specialized care in medical oncology and hematology. Dr. Zhang completed her M.D. and Ph.D. training at Sun Yat-Sen University and Washington State University, respectively. She furthered her medical education with a residency in Internal Medicine at SUNY Downstate Medical Center and a fellowship in Hematology-Oncology at the University of Arkansas for Medical Sciences. She is board certified by the American Board of Internal Medicine in Internal Medicine, Hematology, and Medical Oncology. Her clinical expertise encompasses general medical oncology and both benign and malignant hematology. Dr. Zhang's research interests span cancer biology, health disparities in oncology, autoimmune disorders, and liver diseases. She has contributed to significant research in areas including structural racism's impact on cancer mortality, autoimmune hepatitis manifestations related to COVID-19, and primary biliary cholangitis. Dr. Zhang's publication record shows consistent scholarly activity with recent contributions in 2024, 2023, and 2020, demonstrating her engagement with both clinical practice and research. Her work spans multiple disciplines including oncology, hematology, hepatology, and public health, reflecting a broad research portfolio that addresses both specialized medical conditions and broader health system issues. Board Certified in Internal Medicine, Hematology, and Medical Oncology Active researcher with publications in high-impact journals Specialized expertise in complex oncological and hematological conditions Dr. Zhang maintains an active clinical practice at the Fred Hutchinson Cancer Center while contributing to academic medicine through teaching and research. Her work bridges clinical care with scholarly investigation, particularly in areas where social determinants intersect with cancer outcomes.

Nicole Sextonمشاهده پروفایل

استادیار

• Virology
• Viral Genetics
• Arboviruses
• +۵ مورد دیگر

Nicole R. Sexton, PhD is an Assistant Professor at the University of Nebraska-Lincoln in the School of Biological Sciences and the Nebraska Center for Virology. Her research focuses on viral genetic adaptations that permit viruses to survive and flourish in alternating host environments, particularly RNA arboviruses that cycle between arthropod and vertebrate hosts. Education: Postdoctoral fellowship, Colorado State University Ph.D., Vanderbilt University B.S., University of California – Santa Cruz A.S., Santa Rosa Junior College Dr. Sexton's research interests center on viral genetic robustness, particularly in pathogenic viruses that cycle between arthropod and vertebrate hosts. She investigates how arboviruses like Zika, chikungunya, Dengue, Japanese encephalitis, and Rift Valley fever viruses balance high mutation rates with cyclical transmission between different host species. Her work examines viral strategies to evade distinct immune functions across host species, how viral genetic robustness affects infection in different hosts, how arboviral populations prevent disruption from deleterious mutations while maintaining diversity for selection, and the distinct pressures applied to arboviruses from their arthropod hosts. Analysis of Dr. Sexton's recent publications (2016-2023) reveals a strong focus on viral evolution, particularly in arboviruses and coronaviruses. Her work spans molecular virology, host-virus interactions, viral genetics, and epidemiology. Key themes include viral adaptation to multiple hosts, mutation rates and genetic diversity, vector competence, and SARS-CoV-2 transmission dynamics. Her research employs multi-tiered approaches including bioinformatics, computational comparisons, molecular biology, classical virology, mosquito infections, and high-throughput sequencing technologies. Dr. Sexton leads the Sexton Lab at the University of Nebraska-Lincoln, which investigates mechanisms of efficient spread by arboviruses and virus traits associated with host preferences. The lab utilizes various approaches to study host-virus interactions, with a particular focus on how viruses maintain genetic robustness while adapting to alternating host environments.

Kelli L. Barrمشاهده پروفایل

دانشیار

• Virology
• Infectious Diseases
• Epidemiology
• +۴ مورد دیگر

Kelli L. Barr, PhD serves as an Associate Professor of Microbiology at Lake Erie College of Osteopathic Medicine (LECOM), bringing over 15 years of specialized expertise in virology and infectious disease research to her academic role. Her position bridges laboratory investigation with real-world public health applications, focusing on critical gaps in diagnostic practices for emerging pathogens. Dr. Barr's educational journey includes a B.S. in English Literature and Classical Studies from Iowa State University, followed by a Ph.D. in Insect, Plant, and Microbial Sciences from University of Missouri-Columbia (2008). She completed dual postdoctoral training in Molecular Virology at Florida Gulf Coast University and Global Health Virology at University of Florida, establishing her interdisciplinary approach to infectious disease research. Her research program centers on vector-borne disease epidemiology within changing climate and social contexts, with particular emphasis on diagnostic decision-making for arboviral encephalitis. Dr. Barr combines epidemiological analysis with practical public health applications, maintaining expertise in both vector-borne and zoonotic viruses. Her collaborative work spans international settings, including partnerships that established WHO-designated regional diagnostic centers for emerging pathogens, demonstrating significant global health impact. Analysis of Dr. Barr's recent publications reveals consistent focus on Chikungunya virus pathogenesis across multiple organ systems, West Nile Virus seroprevalence patterns, and innovative approaches to blood donor screening for arboviruses. Her work demonstrates methodological diversity spanning hospital-based epidemiological studies, international field research, and advanced in vitro modeling using cerebral organoids, with increasing attention to neurological complications of viral infections. Dr. Barr actively pursues research opportunities examining occupational exposures of first responders to emerging infections, reflecting her commitment to translating laboratory findings into practical health protection measures for vulnerable populations. Her work bridges academic research with immediate public health applications, particularly in diagnostic capacity building and surveillance system improvement.

Jonas Klingströmمشاهده پروفایل

استاد

• Zoonotic Viruses
• Hantavirus Pathogenesis
• Coronavirus Immunology
• +۳ مورد دیگر

Professor Jonas Klingström is affiliated with Linköping University's Department of Biomedical and Clinical Sciences (BKV), within the Faculty of Medicine and Health Sciences. His research focuses on understanding the mechanisms of zoonotic viruses, particularly hantaviruses and coronaviruses, investigating how these pathogens modulate inflammatory responses and cell-cell signaling. Key interests include viral pathogenesis, immune system interactions, and developing treatments for hantavirus-related diseases like hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). His work combines clinical samples from patients with in vitro models using primary endothelial and immune cells. Notable contributions include elucidating the role of IL-6 trans-signaling in hantavirus-induced barrier dysfunction and identifying immunological factors linked to disease severity. Research also extends to SARS-CoV-2, examining immune responses in immunocompromised individuals and vaccine efficacy. Professor Klingström leads the Molecular Medicine and Virology Division (MMV), integrating molecular biology studies with biomedical education programs. His team collaborates on antiviral drug discovery, such as macropinocytosis inhibitors, and improving viral isolation logistics for public health applications. Recent publications span hantavirus classification updates, SARS-CoV-2 immune correlates, and viral protein network analyses. No scientific awards are explicitly listed in the provided text. His research group actively explores translational approaches to combat viral diseases through a combination of fundamental science and clinical relevance.

Jeff F. Millerمشاهده پروفایل

استاد

• Microbiology
• Immunology
• Molecular Biology
• +۴ مورد دیگر

Jeff F. Miller is a Professor in the Department of Microbiology, Immunology & Molecular Genetics (MIMG) at the University of California, Los Angeles (UCLA). His research focuses on understanding mechanisms of pathogen survival and adaptation, particularly through diversity-generating retroelements (DGRs) in bacteria and phages, and their implications for vaccine development and infection control. Positions: Principal Investigator on multiple NIH grants focusing on microbial pathogenesis and vaccine vectors Research Themes: Bacterial pathogenesis, phage biology, type III secretion systems, and immunological responses His work spans from fundamental studies of bacterial evolution to translational research in vaccine design and antimicrobial strategies. Notable contributions include elucidating the role of DGRs in generating protein diversity and mechanisms of intracellular bacterial survival. Miller has held leadership roles in NIH-funded training programs in microbial pathogenesis. Publications highlight interdisciplinary approaches, combining structural biology, genomics, and immunology to address challenges in infectious diseases. His lab collaborates across disciplines to advance understanding of host-pathogen interactions and apply findings to clinical solutions.

• Photonics
• Biosensors
• Nanotechnology
• +۳ مورد دیگر

Brian T. Cunningham is a distinguished academic holding multiple professorships and leadership roles at the University of Illinois at Urbana-Champaign. He serves as the Intel Alumni Endowed Chair in Electrical and Computer Engineering (ECE), Program Leader at the Cancer Center at Illinois, and Professor in departments including Bioengineering, Micro and Nanotechnology Lab, Biomedical and Translational Sciences, Nutritional Sciences (Affiliate), Chemistry, and the Beckman Institute for Advanced Science and Technology. He also directs the Center for Genomic Diagnostics at the Carl R. Woese Institute for Genomic Biology. His research focuses on advanced biosensor technologies, photonic crystal engineering, and nanotechnology-driven diagnostics. Key areas include photonic crystal-enhanced fluorescence, label-free detection systems, and portable point-of-care devices. His work integrates photonics, plasmonics, and DNA-based nanostructures for ultrasensitive viral and molecular diagnostics. Notable honors include AAAS Fellow (2016), AIMBE Fellow (2013), and IEEE Fellow (2012). He leads interdisciplinary teams in the Micro and Nanotechnology Lab and collaborates across engineering, biomedical, and genomic fields to advance diagnostic tools for healthcare and biomedical research. Research Themes: Photonic crystals, biosensors, nanotechnology, medical diagnostics, and DNA-based nanodevices. Labs/Initiatives: Micro and Nanotechnology Lab, Center for Genomic Diagnostics, Personalized Nutrition Initiative. Technology Highlights: PRAM (Photonic Resonator Absorption Microscopy), DNA NanoGripper, and smartphone-linked diagnostic platforms.

• Biomedicine
• Immunology
• Medical Microbiology
• +۴ مورد دیگر

Dr. Jessica Browne is a Lecturer in the Department of Human Sciences at Southern Cross University's Faculty of Health. She holds dual Bachelor of Biomedical Science degrees (Honours and CQU) and a PhD from Central Queensland University. Her research focuses on molecular microbiology and immunology, particularly host-microbe interactions in otitis media and respiratory diseases, aiming to develop effective vaccines and treatments. Education: BBiomedSc (Central Queensland University) BBiomedSc (Honours) (Central Queensland University) PhD (Central Queensland University) Research Interests: Immunity to mucosal pathogens (e.g., Streptococcus pneumoniae, Haemophilus influenzae), pathogenic mechanisms of otitis media, novel compound bioactivity for respiratory disease treatment, and improved screening methods for otopathogens. Awards: 2021 Inspiring Educators Award (Southern Cross University) Teaching & Supervision: Teaches Immunology, Microbiology, and Clinical Microbiology. Supervises research on anti-inflammatory compounds for respiratory diseases. Serves as a Visiting Researcher at Griffith University (Gold Coast).